Vanderbilt University Makes New Investment in Sabra Healthcare REIT, Inc. $SBRA

Vanderbilt University bought a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 48,483 shares of the real estate investment trust’s stock, valued at approximately $918,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Founders Capital Management bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter valued at about $28,000. Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter valued at about $30,000. Larson Financial Group LLC grew its position in shares of Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 553 shares during the last quarter. Covestor Ltd grew its position in shares of Sabra Healthcare REIT by 23,720.0% in the 3rd quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 2,372 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in shares of Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after buying an additional 1,536 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Analyst Upgrades and Downgrades

SBRA has been the topic of a number of analyst reports. Citizens Jmp upped their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Wells Fargo & Company upped their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, March 26th. Scotiabank upped their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research report on Monday, March 2nd. Truist Financial upped their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Friday, March 13th. Finally, Cantor Fitzgerald upped their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Sabra Healthcare REIT presently has an average rating of “Moderate Buy” and an average target price of $22.00.

Sabra Healthcare REIT Stock Up 1.5%

Shares of Sabra Healthcare REIT stock opened at $20.01 on Wednesday. Sabra Healthcare REIT, Inc. has a one year low of $15.75 and a one year high of $21.07. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. The stock’s 50-day moving average is $19.89 and its 200 day moving average is $19.11. The firm has a market cap of $5.05 billion, a price-to-earnings ratio of 31.27, a PEG ratio of 1.58 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. During the same quarter in the previous year, the company earned $0.36 EPS. The firm’s revenue for the quarter was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Friday, February 13th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio is presently 187.50%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.